Multinational, Multicenter, Non Interventional Study, in Patients With Rheumatoid Arthritis (RA) Treated With Tocilizumab
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2016
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 01 Nov 2016 Status changed from active, no longer recruiting to completed.
- 04 May 2016 Status changed from recruiting to active, no longer recruiting.
- 01 Oct 2015 Planned number of patients changed from 270 to 169 as reported by ClinicalTrials.gov.